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A B S T R A C T
Objective: The identiﬁcation of precancerous lesions is the basis of an early diagnosis, and of a treatment
that allows, in the great part of cases, the preservation of organ functions. The aims of this study were:
the evaluation of the less invasive treatment for precancerous lesion of the larynx to minimize the
recurrences, the estimation of number of further operation required.
Methods: A prospective study was done on patients with clinical diagnosis of laryngeal precancerosis.
The patients were treated by a transoral endoscopic approach with direct microlaryngoscopy (DML)
doing an excision-biopsy with cold blade, consisting in excision of the whole visible lesion with vocal
ligament preservation.
Results: A recurrence of a clinically evident precancerous lesionwas present in 13.2% of patients that had
a laryngeal intraepithelial lesion (LIN) 1 lesion and in 28.95% of patients that had a LIN 2 lesion.
Conclusion: In order to achieve a control of a precancerous lesion, we suggest: excisional biopsy/
subepithelial cordectomy (type 1 cordectomy) for LIN 1 lesions and subligament cordectomy (type 2
cordectomy) in case of LIN 2 cases. In case of recurrences of LIN 1 lesion we suggest directly a type 2
cordectomy.
 2011 Elsevier Ireland Ltd. All rights reserved.1. Introduction
The prevention of neoplastic diseases is realized by identiﬁca-
tion of mechanism underlying the carcinogenesis and by the
knowledge of clinical pictures that indicate a precancerous
conditions that may evolve to cancer, although not necessarily.
The WHO classiﬁed precancerous lesions as ‘‘progressive
morphologic alteration of the epithelium because of irritating
chronic local factor or referable to a local expression of generalized
illness, presenting a higher probability of degeneration into
carcinoma with respect to the surrounding mucosa’’ [1].
The clinical lesions recognized as precancerous in literature are
called variously: leukoplakia, erythroplakia, erythrokeratosis,
dyskeratosis, white lesion, keratosis, but generally all are deter-
mined by a chronic laryngitis. It has now been unanimously
recognized that the classiﬁcation of precancerous lesions must be
based on the progression of the speciﬁc histopathological
characteristics, which in turn considers the grade of epithelial
hyperplasia and dysplasia [2].* Corresponding author. Fax: +39 091442084.
E-mail address: francesco.dispenza@gmail.com (F. Dispenza).
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doi:10.1016/j.anl.2011.08.002Kleinsasser described two clinical forms macroscopically
detec: the limited epithelial hyperplasia and the hyperplasic
chronic laryngitis [3].
In 1974 Bocca et al. identiﬁed clinically the precancerous
condition in the keratosic epithelial hyperplasia of the vocal cord,
distinguished in two macroscopic forms: plane and raised [4].
To standardize the medical terminology on precancerous lesion
of the larynx, the terms keratosis or leukoplakia, describing only
the clinical condition, should be adoptedwithout histopathological
meaning. In fact, several histological features could be found under
the same clinical lesion.
The histopathological alterations noticed in the larynx pre-
cancerosis are: epithelial hyperplasia, epidermoid metaplasia,
acanthosis, keratosis, dyskeratosis, pachydermia, dysplasia.
Hellquist et al. proposed the following classiﬁcation: (I)
hyperplasia with or without low dysplasia; (II) moderate dyspla-
sia; (III) severe dysplasia or in situ carcinoma [5].
The dysplasia is thus considerate an early tumor limited to the
epithelial layer, hence Friedmann proposed a classiﬁcation getting
idea from the classiﬁcation of uterine precancerous lesions [6]. He
divided the precancerous lesions into two groups: keratosiswithout
dysplasia and keratosis with dysplasia. The latter was subdivided
into three groups according with the grade of dysplasia: LIN 1
(lowgrade), LIN 2 (moderate grade), LIN 3 (high grade); the termLIN
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also with carcinoma in situ (CIS).
The aims of this study were: the evaluation of the less invasive
treatment for precancerous lesion of the larynx to minimize the
recurrences, the estimation of number of further operation
required.
2. Methods
A prospective study was done on patients with clinical
diagnosis of laryngeal precancerosis in the period 2004–2005.
All consecutive patients presenting a vocal cord precancerous
lesionwere enrolled in the study. The criteria to consider as eligible
a patient were: leukoplakic or keratosic lesion of the vocal cord,
erytroplakia or erytrokeratosis, normal motility of the vocal cord
and the arythenoid, no previous laryngeal surgery, no previous
tracheal intubations. The term leukoplakia and keratosis were
considered as equal, specifying only the morphological features as
plane or raised respect to the normal mucosa. A history was
collected with particular attention to risk factor presence (tobacco
smoke, works environments, alcohol). All patients enrolled
underwent to head and neck examination, ﬁberoptic laryngoscopy,
and vocal performance questionnaire (VPQ: 12 questions with a
score of 1–5). The patients were treated by a transoral endoscopic
approach with direct microlaryngoscopy (DML) doing an excision-
biopsy with cold blade, consisting in excision of the whole visible
lesion with vocal ligament preservation. A histopathological[(Fig._1)TD$FIG]
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Fig. 1. Flow chart of the management of the Precancerous Lesion, revised after our r
carcinoma).examination was obtained in all cases classifying the results
according with Friedmann. The patients were followed-up every 2
months for the ﬁrst year and every 6 months in subsequent years.
The clinical follow-up was done with ﬁberoptic laryngoscopy.
In case of diagnosis of early glottic cancer after the ﬁrst
operation the patients are treated by a transmuscular cordectomy
(type 3) under DML. In case of recurrence of the disease during
follow-up we adopt a type 4 cordectomy under DML. All patients
exhibiting a cancer recurrence after the ﬁrst treatment are
managed with open surgery as fronto-lateral laryngectomy and
supracricoid laryngectomy (Fig. 1).
The preoperative records, the data obtained after surgery and
the results after follow-up were analyzed statistically.
3. Results
The patients examined and treated included in the study were
232. The mean age was 59 years (range 34–82 years). The male/
female ratio was 8:1. 86% of patients were smokers. 43% of patient
resulted alcohol consumer of more than 30 ml/day. The patients
were ﬁrstly classiﬁed according to the clinical diagnosis: plane
keratosis in 81 cases (Fig. 2), raised keratosis in 80 cases (Fig. 3),
and erythrokeratosis in 71 cases. The surgical operation consisted
in the excision of the whole visible lesion with preservation of the
vocal ligament. The histopathological examination showed a
variable grade of dysplasia that was classiﬁed in accordance with
Friedmann: LIN 1 in 53 cases, LIN 2 in 76 cases and LIN 3/CIS in 46f the vocal cord 
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Fig. 3. Direct laryngoscopic view of a raised keratosis of the left vocal cord.
Table 2
Recurrence rates in patients that had low and mild dysplasia.
LIN 1 (53) LIN 2 (76)
Recurrence of precancerous lesion 7 cases (13.2%) 22 cases (29%)
Cancer development among
LIN1-2 patients
None 12 cases (9.3%)
[(Fig._2)TD$FIG]
Fig. 2. Direct laryngoscopic views of a plane keratosis of the right vocal cord, the
lesion involve the medial aspect of the vocal cord.
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identiﬁed in 57 cases (Table 1).
A stratiﬁcation of histopathological ﬁndings with the clinical
features revealed the incidence of LIN 3/CIS in relationwith clinical
appearance: 16 cases among plane keratosis, 21 cases among
raised keratosis, and 9 cases among erythrokeratosis. The 57
patients with mSCC were stratiﬁed as follows: 13 patients withTable 1
Correlation between clinical features of precancerous lesions and histopathology.
The clinical features are often not indicative of the underlying malignancy. LIN
(laryngeal intraepithelial lesion); mSCC (microinvasive squamous cell carcinoma).
Plane keratosis Raised keratosis Erythrokeratosis
LIN 1 23 (9.9%) 13 (5.6%) 17 (7.3%) 53 (22.8%)
LIN 2 29 (12.5%) 26 (11.2%) 21 (9.1%) 76 (32.7%)
LIN 3 16 (6.8%) 21 (9.1%) 9 (3.9%) 46 (19.8%)
mSCC 13 (5.6%) 20 (8.6%) 24 (10.3%) 57 (24.6%)
81 (34.9%) 80 (34.5%) 71 (30.6%) 232plane keratosis, 20 patients with raised keratosis and 24 patients
with erythrokeratosis (Table 1).
The analysis of the VPQ scores showed a mean preoperative
value of 32.5 points (SD 9.1), while the follow-up test at 3 months
showed a mean value of 18.4 (SD 7.1).
The overall incidence of an early glottic carcinoma in case of
clinically diagnosed precancerous lesion was of 24.6% (Table 1).
The patients with diagnosis of early glottic cancer after the
excision-biopsy underwent to a further operation of total
cordectomy type 3 by a transoral endoscopic approach with direct
microlaryngoscopy. The patients with diagnosis of LIN 1 and LIN 2
were strictly followed-up.
After 5 years of follow-up we recorded the incidence of the
recurrence in all patients. A recurrence of a clinically evident
precancerous lesion was present in 13.2% of patients that had a LIN
1 lesion and in 29.0% of patients that had a LIN 2 lesion (Table 2).
The patients exhibiting recurrence were treated surgically with a
type 4 cordectomy. Among recurrences of keratosic lesion, 12
(9.3%) had a diagnosis of carcinoma after the second treatment; all
these patients had a previous LIN 2 lesion. In the group of patients
with a previous early glottic cancer, and treated initially with type
3 cordectomy, a recurrencewas observed in 5 patients (4.9%), these
patients underwent to Dispenza’s modiﬁed fronto-lateral laryn-
gectomy [7] or supracricoid laryngectomy.
4. Discussion
The laryngeal cancer represents about 1–2% of all malignant
tumors. In 90% of cases carcinomas develop from precancerous
epithelial lesions [8]. Prompt treatment after an early diagnosis is
capable to prevent the development of an invasive neoplasm and
the consequent recourse to more invasive laryngeal surgery [3,9].
The theory of the transformation of laryngeal keratosis into
carcinoma, which occurs through progressive modiﬁcations of
normal epithelium in keratosis without dysplasia, or the point of
degenerating into carcinoma in situ, is conﬁrmed by epidemiologi-
cal data and the tendency to relapse to a more advanced stage of
dysplasia [8]. The concept of pre-invasive lesion hasmore correctly
replaced that of precancerous lesion. This idea came up because
carcinoma in situ is classiﬁed in the group of severe dysplasia
progressing from an intraepithelial neoplasm; consequently a
carcinoma in situ should not be considered as a precancerous
lesion but as a pre-invasive lesion.
The carcinoma in situ is characterized by a higher incidence of
recurrences of both dysplasia and inﬁltrating carcinoma as showed
by some Authors [10–12], and for that reason it should be
considered separately from simple dysplasia in term of prognosis
and classiﬁcation [12].
We pointed out elsewhere thatmost of malignant tumors of the
larynx develop from precancerous lesions [13]. As described by
Gallo et al. the interval between the ﬁrst diagnosis of a laryngeal
dysplasia and the discovery of the malignant tumor seems to be
correlated with the grade of dysplasia [14]. In fact, is a common
consideration that the evolution of preinvasive lesion to inﬁltrat-
ing disease could be prevented by an early diagnosis and an
accurate treatment.
As reported by several study, the recurrence of a dysplastic
lesion ranges between 9.5 and 46.4%, and the type of treatment
Table 3
Treatment of precancerous lesion and relative recurrence rate of some Authors. The recurrence rate seems to be unlinked to the approach selected.
Authors Patients Surgery LIN 1 Recurrence LIN 2 Recurrence SCC
Gallo 84 Cordectomy Type 1 and 3 56 14 (25%) 28 13 (46%) 10
Plch 88 Cordectomy Type 1 63 9 (14%) 25 3 (12%) 1
Leirens 32 Cordectomy Type 1 25 3 (12%) 7 1 (14%) 1
Minni 58 Cordectomy Type 1 and 2 32 4 (12%) 26 1 (8%)
Ricci 78 Excision Biopsy 42 4 (10%) 36 6 (17%) 5
F. Dispenza et al. / Auris Nasus Larynx 39 (2012) 280–283 283was not determinant to the ﬁnal results [8,15–18] (Table 3). The
excision biopsy alone does not seem to present higher recurrence
rates compared to simple cord stripping or type 1 cordectomy [16].
For this reason we preferred to adopt a more conservative surgery
in case of suspect lesions limited to a little portion of the vocal cord.
The excision biopsy allows also performing a single intervention to
reach a good result in term of avoiding recurrence.
As easily imaginable, a lower recurrence rate is achieved with a
more aggressive treatment and, if similar functional results were
obtained after more aggressive treatments (type 2 cordectomy),
this would seem to suggest a more radical surgical treatment even
for mild forms of dysplasia.
In our opinion this approach may be sometimes questionable,
because aggressive treatments without a histopathological conﬁr-
mation could be overtreatments.
The follow-up is, however, a crucial step after the surgery to
prevent invasive disease in case of recurrence, monitoring the
patients for the months and years after surgery, especially those
with higher grade of dysplasia.
The control of the risk factors covers the same importance of the
postoperative follow-up, because 80% of recurrences occurred in
patients who continued alcohol consuming or smoking [8]. The
presence of gastroesophageal reﬂux is now considered also
between risk factors of laryngeal dysplasia recurrence [19], and
it should evaluated and treated taking into consideration that
about 30% of subjects are asymptomatic.
Among patients with recurrent keratosic laryngeal lesion, we
noted a cancer development in 12 (9.3%) cases, all linked to a LIN 2
lesion. Our recurrence rate (13.2% for LIN1 and 29.0% for LIN2) was
similar to those reported in literature as Table 3 shows. In 5
patients out from those with early glottic cancer and treated by
type 3 cordectomy we recorded a recurrence of cancer.
The intriguing ﬁnding that emerges is that in cases of
recurrence after cordectomy in moderate dysplasia we have not
malignancy development. The low dysplasia (LIN 1) managed with
conservative techniques as excision biopsy and type 1 cordectomy,
may present some recurrence rate, while surprisingly this does not
happen in more severe forms. This is due to a more extensive
resection as type 2 cordectomy that is adopted for laryngeal
preinvasive lesions that clinically, or histopathologically when
available, look as more aggressive.
However the clinical appearance of the preinvasive laryngeal
lesion is not related to the ﬁnal histopathology results as showed
by our series. This indication suggests that it is very difﬁcult to
predict the recurrence and thus the needs of further treatment only
by a clinical feature.
The low recurrence rate observed in case of clinically more
aggressive lesion (that histologically resulted as LIN 3, Cis or
microinvasive carcinoma) is clearly linked to the more aggressive
treatment performed as ﬁrst approach. The LIN 2 lesion is, thus, the
precancerous form that may cause the higher rate of recurrence
due to a less aggressive treatment, because is often undistinguish-
able clinically from a LIN 1 lesion. The lesson learned from this
study should be that in case of LIN 2 lesion different treatment
strategy could be indicated. In our opinion the way adoptable aretwo: a ﬁrst biopsy to ascertain the grade of dysplasia before the
excision or a further surgical treatment in case of LIN 2 evidence
after ﬁrst examination.
5. Conclusions
In order to achieve a control of a precancerous lesion,
minimizing the recurrence rate and preserving a good voice
quality, we suggest: excisional biopsy/subepithelial cordectomy
(type 1 cordectomy) for LIN 1 lesions and subligament cordectomy
(type 2 cordectomy) in case of LIN 2 cases. In case of recurrences of
LIN 1 lesionwe suggest directly a type 2 cordectomy. The physician
should keep inmind that the control of risk factor could reduce the
recurrence rate. A prolonged follow-up is absolutely necessary.
References
[1] WHO. Collaborating center for oral precancerous lesions. Deﬁnition of leuko-
plakia and related lesions: an aid to studies on oral precancer. Oral Surg
1987;46:518–39.
[2] Pallestrini EA, Borasi F, Garaventa G, Parmegiani A. Laryngeal precancerous
conditions. Acta Otorhinolaryngol Ital 1991;33:7–17.
[3] Kleinsasser O. Die Klassiffcation und diVerential diagnose der epithelyperpla-
sien der Kehlkopfschleimhaut auf Grund Histomorphologischer Merkmale.
Zschr Laryng Rhinol 1963;42:339–62.
[4] Bocca E, Leonardelli GB, Micheu C, Pignataro O. Gli stati precancerosi della
laringe. Nuovo Arch Ital Otol 1974;2:287–305.
[5] Hellquist H, Lundgren J, Oloffson J. Hyperplasia keratosis, dyslasia and carci-
noma in situ of the vocal cords, a follow-up study. Clin Otolaryngol 1982;7:
11–27.
[6] Friedmann I. Precancerous lesions of larynx. Can J Otolaryngol 1987;22:
311–52.
[7] Dispenza F, Saraniti C, Mathur N, Dispenza C. Modiﬁed fronto-lateral laryn-
gectomy in treatment of glottic T1(a-b) cancer with anterior commissure
involvement. Auris Nasus Larynx 2010;37:469–73.
[8] Minni A, Barbaro M, Rispoli G, Diaferia F, Bernardeschi D, Filipo R. Treatment
with laser CO2 cordectomy and clinical implications in management of
mild and moderate laryngeal precancerosis. Eur Arch Otolaryngol 2008;265:
189–93.
[9] Malzahn K, Dreyer T, Glanz H, Arens C. Autoﬂuorescence endoscopy in the
diagnosis of early laryngeal cancer and its precursor lesions. Laryngoscope
2002;112:488–93.
[10] Ngoyen C, Naghibzadeh B, Black MJ, Rochon L, Shenouda G. Carcinoma in situ
of the glottic larynx: excision or irradiation? Head Neck 1996;18:225–8.
[11] Stenersen TC, Hoel PS, Boysen M. Carcinoma in situ of the larynx: results with
different methods of treatment. Acta Otolaryngol 1988;449:1–133.
[12] Blackwell KE, Calcaterra TC, Fu Y. Laryngeal displasia: epidemiology and
treatment outcome. Ann Otol Rhinol Laryngol 1995;104:596–602.
[13] Salzano FA, Dispenza F, Speciale R, Dispenza C. Larynx carcinoma
epidemiology. In: Salami A, editor. Identiﬁcazione dei marcatori prognostici
nel tumore della laringe. Torino: Minerva Medica; 2009. p. 27–31.
[14] Gallo A, de Vincentiis M, Della Rocca C, Moi R, Simonelli M, Minni A, et al.
Evolution of precancerous laryngeal lesion: a clinicopathologic study with
long-term follow-up on 259 patients. Head Neck 2001;23:40–7.
[15] Sadri M, McMahon J, Parker A. Management of laryngeal dysplasia: a review.
Eur Arch Otorhinolaryngol 2006;263:843–52.
[16] Ricci G, Molini E, Faralli M, Simoncelli C. Retrospective study on precancerous
laryngeal lesion: long-term follow-up. Acta Otorhinolaryngol Ital 2003;23:
362–7.
[17] Plch J, Par I, Navratilova I, Blahova M, Zavadil M. Long term follow-up of
laryngeal precancer. Auris Nasus Larynx 1998;25:407–12.
[18] Leirens J, Vidts G, Schmelzer B, Delle Faille D, Katz S, Van Cauwenberge P.
Premalingnant lesion of the vocal fold: a retrospective study of 62 cases. Acta
Otolaryngol 1997;117:903–8.
[19] Peretti G, Piazza C, Berlucchi M, Cappiello J, Giudice M, Nicolai P. Pre-and
intraoperative assessment of mid-cord erythroleukoplakias. A prospective
study on 52 patients. Eur Arch Otorhinolaryngol 2003;260:525–8.
